HSF1 and neoplasm: Elevated HSF1 expression is associated with higher Gleason scores and metastasis, and DTHIB, a direct HSF1 inhibitor, stimulates HSF1 degradation and inhibits xenograft tumor growth of CRPC cells10, suggesting HSF1 as a critical therapeutic target for mCRPC progression.